Even when breast cancer gene is negative, risk still persists - WXOW News 19 La Crosse, WI – News, Weather and Sports |

Even when breast cancer gene is negative, risk still persists

Posted:
  • HealthMore>>

  • Deal to improve veterans' health care costs $17B

    Deal to improve veterans' health care costs $17B

    Monday, July 28 2014 2:37 PM EDT2014-07-28 18:37:29 GMT
    After more than six weeks of sometimes testy talks, House and Senate negotiators have agreed on a compromise plan to fix a veterans health program scandalized by long patient wait times and falsified records...More >>
    A bipartisan deal to improve veterans' health care would authorize at least $17 billion to fix the health program scandalized by long patient wait times and falsified records covering up delays, the bill's chief...More >>
  • Medicare hospital fund to last 4 years longer

    Medicare hospital fund to last 4 years longer

    Monday, July 28 2014 2:13 PM EDT2014-07-28 18:13:04 GMT
    The government says Medicare's finances have improved. The program's hospital trust fund won't be exhausted until 2030 - four years later than last year's estimate.More >>
    Medicare's finances are looking brighter, the government said Monday. The program's giant hospital trust fund won't be exhausted until 2030 - four years later than last year's estimate.More >>
  • New fears about Ebola spread after plane scare

    New fears about Ebola spread after plane scare

    Monday, July 28 2014 1:32 PM EDT2014-07-28 17:32:55 GMT
    No one knows for sure just how many people Patrick Sawyer came into contact with the day he boarded a plane in Liberia, had a layover in Togo and then arrived in Nigeria where authorities say he died days later...More >>
    No one knows for sure just how many people Patrick Sawyer came into contact with the day he boarded a plane in Liberia, had a layover in Togo and then arrived in Nigeria where authorities say he died days later from Ebola,...More >>

SATURDAY, November 30, 2013 (HealthDay News) -- Women with a family history of breast cancer often want to get tested for the BRCA1 and BRCA2 genetic mutations linked to the disease.

But a new study suggests that even if a woman tests negative for the BRCA2 gene, she could still be at increased risk for breast cancer.

"With the recent revelation that Angelina Jolie tested positive for the BRCA gene, many patients have been asking questions regarding genetic testing," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. "The general public wants to know what a positive or negative test really means."

Until now, it's been thought that women in families with BRCA mutations who themselves test negative for the gene would have the same risk for breast cancer as women in the general population.

But that may not always be true, according the study, which was published Nov. 27 in the journal Cancer Epidemiology, Biomarkers & Prevention.

The researchers analyzed data from more than 800 families in England with BRCA mutations. They found that 49 women in those families who tested negative for the family-specific BRCA mutation later went on to develop breast cancer.

Dr. Gareth Evans is an honorary professor of medical genetics and cancer epidemiology at the University of Manchester, in England. "We found that women who test negative for family-specific BRCA2 mutations [still] have more than four times the risk for developing breast cancer than the general population," Evans said in a journal news release.

"We also found that any increased risk for breast cancer is largely limited to BRCA2 families with strong family history and other genetic factors," he said. "It is likely that these women inherit genetic factors other than BRCA-related genes that increase their breast cancer risk."

Evans said about 77 genetic mutations are currently known to be linked with breast cancer risk. Researchers need to identify additional mutations in order to understand why some BRCA-negative women from families with BRCA mutations still have a higher risk for breast cancer, he said.

Bernik said genetic tests may not tell the whole story when it comes to cancer risk.

"Although the risk of getting cancer is not as high [for women who test negative for BRCA2] as that of a gene carrier, it appears to be elevated," she said. "The numbers in this study were not large enough to prove this definitively, but certainly it raises the issue that more attention needs to be given to every family member in genetically susceptible lineages."

Dr. Elisa Port, chief of breast surgery at the Dubin Breast Center, part of the Mount Sinai Health System in New York City, said getting reliable results from a gene test is key to good care.

"Providing patients with accurate information on their risk for developing breast cancer in the future is critical for decision making regarding different options and interventions," Port said. These measures include preventive mastectomy, the option Jolie chose, or taking the anti-breast cancer drug tamoxifen.

The new study suggests that women "who test BRCA-negative are not completely off the hook regarding a higher risk of developing breast cancer," said Port, who is also an associate professor of surgery at the Icahn School of Medicine at Mount Sinai. "More information like this will hopefully help us refine our treatment and recommendations for the individual patient."

More information

The U.S. National Cancer Institute has more about BRCA mutations and cancer risk.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WXOW. All Rights Reserved.
For more information on this site, please read our Privacy Policy, Terms of Service and Mobile Privacy Policy & Terms of Service.

Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Theresa Wopat at 507-895-9969. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at fccinfo@fcc.gov.